Post Menopausal Vaginal Atrophy Market

(Albany, US) DelveInsight’s “Post Menopausal Vaginal Atrophy Market Insights, Epidemiology, and Market Forecast-2032” report provides an in-depth understanding of the disease, historical and forecasted epidemiology, as well as Post menopausal vaginal atrophy market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Some of the key facts of the Post Menopausal Vaginal Atrophy Market

  • According to the American Association of Family Physicians, up to 40 percent of postmenopausal women have symptoms of atrophic vaginitis. While 15% of the female population experiences symptoms of vaginal atrophy before menopause.
  • While vaginal atrophy is common, only 20 to 25 percent of symptomatic women seek medical attention from their doctor.
  • European Vulvovaginal Epidemiological Survey examined >2,000 postmenopausal women. Symptoms of Vaginal Atrophy were detected in 90% of women. According to the results of the survey, the quality of life in this group of women was significantly lower in comparison to that of women of postmenopausal age without symptoms of Vaginal Atrophy.

Request for Sample Report:

https://www.delveinsight.com/sample-request/postmenopausal-vaginal-atrophy-market

View Report: https://www.delveinsight.com/report-store/postmenopausal-vaginal-atrophy-market

Key benefits of the Post Menopausal Vaginal AtrophyMarket report:

  • The study provides a detailed review of Post Menopausal Vaginal Atrophy, including its causes, signs and symptoms, pathophysiology, diagnosis, and current treatments.
  • Study of the 7MM has offered comprehensive insight into the epidemiology and management of Post Menopausal Vaginal Atrophy.
  • Furthermore, an all-inclusive description of both present and emergingPost Menopausal Vaginal Atrophy treatments is offered, as well as an analysis of future therapies that will have an influence on the current treatment landscape.
  • The research includes a full evaluation of the Post Menopausal Vaginal Atrophy market, both historical and anticipated, as well as drug outreach in the 7MM population.
  • By understanding the trends defining and driving the worldwide Post Menopausal Vaginal Atrophy market, the study gives you an advantage when formulating business plans.

Post Menopausal Vaginal Atrophy Overview

Postmenopausal atrophic vaginitis, or vaginal atrophy, is the thinning of the walls of the vagina caused by decreased estrogen levels. Without estrogen, vaginal tissue thins and dries out. It becomes less elastic, more fragile, and more easily injured. This most commonly occurs after menopause. Women with vaginal atrophy have a greater chance of chronic vaginal infections and urinary function problems. It can also make sexual intercourse painful. Symptoms can include: thinning of the vaginal walls, shortening and tightening of the vaginal canal, lack of vaginal moisture, vaginal burning, spotting after intercourse, discomfort or pain during intercourse, pain or burning with urination, more frequent urinary tract infections, and/or urinary incontinence.

Atrophic vaginitis increases a woman’s risk of contracting vaginal infections. Atrophy causes changes in the acidic environment of the vagina, making it easier for bacteria, yeast, and other organisms to thrive. It also increases the risk of urinary system atrophy (genitourinary atrophy). Symptoms associated with atrophy-related urinary tract problems include more frequent or more urgent urination or a burning sensation during urination.

Postmenopausal atrophic vaginitis is often diagnosed through a physical examination, pelvic examination, vaginal smear test, vaginal acidity test, blood test and urine test. With treatment, it’s possible to improve your vaginal health and your quality of life. Estrogen replacement therapy and Over-the-counter moisturizers or water-based lubricants can help treat dryness.

View Report: https://www.delveinsight.com/report-store/postmenopausal-vaginal-atrophy-market

Post Menopausal Vaginal Atrophy Market 

The report’s Post Menopausal Vaginal Atrophy market outlook assists in developing a detailed understanding of historic, current, and forecasted Post Menopausal Vaginal Atrophy market trends by analyzing the impact of current Post Menopausal Vaginal Atrophy therapies on the market, unmet needs, drivers and barriers, and demand for better technology. This section examines the Post Menopausal Vaginal Atrophy market trend of each marketed drug and late stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing market need, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, market impact, and key opinion leaders’ perspectives. Post Menopausal Vaginal Atrophy market statistics are supplied with pertinent tables and graphs to provide a comprehensive picture of the market at a glance. According to DelveInsight, the Post Menopausal Vaginal Atrophy market in 7MM is expected to undergo significant change between 2019 and 2032.

Learn more by requesting for sample @ Post Menopausal Vaginal Atrophy Market Landscape 

Post Menopausal Vaginal Atrophy Companies 

  • Novo Nordisk A/S
  • PepTonic Medical AB
  • Pharma Consulting Group AB 
  • Italfarmaco S.A
  • And Many More

View Report: https://www.delveinsight.com/report-store/postmenopausal-vaginal-atrophy-market

Post Menopausal Vaginal Atrophy Pipeline 

  • Estradiol
  • Estriol
  • Oxytocin
  • And Many More

Know more about the pipeline therapies and recent developments @ Post Menopausal Vaginal Atrophy Pipeline Report

Table of Contents

  1. Key Insights
  2. Executive Summary of Postmenopausal Vaginal Atrophy
  3. Competitive Intelligence Analysis for Postmenopausal Vaginal Atrophy
  4. Postmenopausal Vaginal Atrophy: Market Overview at a Glance
  5. Postmenopausal Vaginal Atrophy: Disease Background and Overview
  6. Patient Journey
  7. Postmenopausal Vaginal Atrophy Epidemiology and Patient Population
  8. Treatment Algorithm, Current Treatment, and Medical Practices
  9. Postmenopausal Vaginal Atrophy Unmet Needs
  10. Key Endpoints of Postmenopausal Vaginal Atrophy Treatment
  11. Postmenopausal Vaginal Atrophy Marketed Products
  12. Postmenopausal Vaginal Atrophy Emerging Therapies
  13. Postmenopausal Vaginal Atrophy: Seven Major Market Analysis
  14. Attribute analysis
  15. 7MM: Market Outlook
  16. Access and Reimbursement Overview of Postmenopausal Vaginal Atrophy
  17. KOL Views
  18. Market Drivers
  19. Market Barriers
  20. Appendix
  21. DelveInsight Capabilities
  22. Disclaimer
  23. About DelveInsight

Click here to read more about Post Menopausal Vaginal Atrophy Market Outlook 2032

Related Reports by DelveInsight:

Other Reports:

Related Blogs:

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact

Company Name: DelveInsight Business Research LLP

Contact Person: Shambhavi Verma

Email: info@delveinsight.com

City: Albany

State: New York

Country: United States

Website: https://www.delveinsight.com

 

Comments

Post a Comment

Popular posts from this blog

How Competitive intelligence is transforming the scenario for Biotech firms?

What is Competitive intelligence service? Competitive intelligence ideally means gathering information on rival business in the market, analyse the information and use the information to strategize to yield positive results. Going by the definition, competitive intelligence assembles actionable information from diverse published and unpublished sources, collected efficiently and ethically. So, analysts performing Competitive intelligence for their clienteles present a detailed picture of the marketplace, forthcoming challenges and the ways to face them, even before the can harm the client’s business. What could it mean? Competitive intelligence can often give a wrong idea, as it may misunderstood as a service which can help gain an advantage over the rivals. However, this is not the case. Competitive intelligence is an ethical and legal practise undertaken involving the study of analytical data, analysing the market and optimizing the relevant and realistic strategies t
Read more

Hypothalamic Obesity Market by DelveInsight

  (New York, USA) DelveInsight’s “ Hypothalamic Obesity Market Insights, Epidemiology, and Market Forecast-2032 ” report delivers an in-depth understanding of Hypothalamic Obesity, historical and forecasted epidemiology as well as the Hypothalamic Obesity market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Hypothalamic Obesity market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Hypothalamic Obesity market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Hypothalamic Obesity treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Hypothalamic Obesity market. Request for a Free Sample Report @  Hypothalamic Obesity Market Forecast Some facts of the Hypothalamic Obesity Market Report are: Accordi
Read more

Test

  Partial Seizure Market | Parkinson's Disease Levodopa-Induced Dyskinesia Market | Metabolic Acidosis Market | Hepatitis D Market | Gaucher's disease Market | Gastric Neuroendocrine Tumours Market | Familial Chylomicronemia Syndrome Market | Exocrine Pancreatic Insufficiency Market | Crohn's Disease Market | Contact Dermatitis Market | Concussions Market Size | Chronic Bronchitis Market | Chondrosarcoma Market | Palmar Hyperhidrosis Market | Hpv Induced Cancers Market | Alstrom Syndrome Market | Astigmatism Market | Meningioma Market | Central Retinal Vein Occlusion Market | Intracranial Pressure Monitoring Devices Market | Head And Neck Squamous Cell Carcinoma Market | Hyperopia Market | Thyroid Eye Disease Market | Rett Syndrome Market | Cipn Market | Chemotherapy Induced Peripheral Neuropathy Market | Idiopathic Membranous Nephropathy Market | Walking Impairment In Multiple Sclerosis Market  |  Triple Negative Breast Cancer Market  | Sjogren&#
Read more